FMS Share Price

Open 41.10 Change Price %
High 41.35 1 Day -0.39 -0.94
Low 41.07 1 Week 0.68 1.68
Close 41.22 1 Month 0.35 0.86
Volume 215389 1 Year -1.66 -3.87
52 Week High 47.52
52 Week Low 38.05
FMS Important Levels
Resistance 2 41.48
Resistance 1 41.37
Pivot 41.21
Support 1 41.07
Support 2 40.96
NYSE USA Most Active Stocks
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
BAC 24.23 -1.42%
BAC 24.23 -1.42%
BAC 24.23 -1.42%
SE 40.68 -0.78%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
More..
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
BBW 10.10 21.69%
FIX 38.65 17.66%
FIX 38.65 17.66%
FNP 35.24 12.02%
FNP 35.24 12.02%
DMD 6.35 9.48%
DMD 6.35 9.48%
FL 75.01 9.38%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Fresenius Medical Care Corporation (NYSE: FMS)

FMS Technical Analysis 1.5
As on 24th Feb 2017 FMS Share Price closed @ 41.22 and we RECOMMEND Sell for LONG-TERM with Stoploss of 42.60 & Buy for SHORT-TERM with Stoploss of 41.09 we also expect STOCK to react on Following IMPORTANT LEVELS.
FMS Target for February
1st Target up-side 42.61
2nd Target up-side 43.89
3rd Target up-side 45.16
1st Target down-side 38.99
2nd Target down-side 37.71
3rd Target down-side 36.44
FMS Other Details
Segment EQ
Market Capital 20783310848.00
Sector Healthcare
Industry Specialized Health Services
Offical website http://www.fmc-ag.com
FMS Address
FMS
Else-Kr
Bad Homburg, 61352
Germany
Phone: 49 6172 6090
Fax: 49 6172 609 2301
FMS Latest News
Interactive Technical Analysis Chart Fresenius Medical Care Corporation ( FMS NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Fresenius Medical Care Corporation
FMS Business Profile
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides renal dialysis products and services. It offers dialysis treatment, and related laboratory and diagnostic services through its network of 3,250 outpatient dialysis clinics in approximately 45 countries worldwide; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S. for the hospitalized ESRD patients and for patients suffering from acute kidney failure. The company also provides pharmacy services, such as delivery and supply of renal medications to patients at homes or to dialysis clinics directly; vascular access surgery services; and manufactures and distributes products for the treatment of end-stage renal disease (ESRD). In addition, it offers laboratory services that include blood, urine, and other bodily fluid testing services; and hemodialysis (HD) machines, modular components for dialysis machines, polysulfone dialyzers, bloodlines, HD solutions and concentrates, needles, connectors, machines for water treatment, data administration systems, dialysis chairs, phosphate binders, iron products, and other renal drug products. Further, the company provides peritoneal dialysis systems and solutions for continuous ambulatory peritoneal dialysis and automated peritoneal dialysis therapy; and adsorbers, which are filters used in other extracorporeal therapies; and distributes specific instruments for vascular access, as well as other supplies, such as bandages, clamps, and injections. It sells its products to clinics, hospitals, and specialized treatment clinics through direct sales forces, local sales forces, independent distributors, dealers, and sales agents. The company was founded in 1996 and is headquartered in Bad Homburg, Germany.